Literature DB >> 7962557

Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.

A J Baker1, A Mooney, J Hughes, D Lombardi, R J Johnson, J Savill.   

Abstract

Increases in mesangial cell number may herald glomerular scarring, but they are not irreversible. This study sought mechanisms by which surplus glomerular mesangial cells can be cleared. A small proportion of cultured mesangial cells exhibited typical morphological features of apoptosis (programmed cell death), which was increased by growth factor deprivation or exposure to cycloheximide, stimuli known to increase apoptosis in other cell types. Apoptosis was confirmed by typical internucleosomal chromatin cleavage. In vivo, clear morphological evidence of mesangial apoptosis leading to phagocytosis by neighboring mesangial cells was obtained in self-limited mesangial proliferation induced in rats by Thy1.1 antibody, apoptosis occurring approximately 10-fold more frequently than in the healthy rat glomerulus. Indeed, changes in glomerular cell number in Thy1.1 nephritis strongly suggested that apoptosis is the major cell clearance mechanism counterbalancing cell division, thereby mediating resolution of glomerular hypercellularity in experimental mesangial proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962557      PMCID: PMC294654          DOI: 10.1172/JCI117565

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

Review 1.  Mesangial cell turnover: effect of heparin and peptide growth factors.

Authors:  L J Striker; E P Peten; S J Elliot; T Doi; G E Striker
Journal:  Lab Invest       Date:  1991-04       Impact factor: 5.662

2.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

Review 3.  Programmed cell death in the immune system.

Authors:  J J Cohen
Journal:  Adv Immunol       Date:  1991       Impact factor: 3.543

4.  Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing.

Authors:  I Darby; O Skalli; G Gabbiani
Journal:  Lab Invest       Date:  1990-07       Impact factor: 5.662

5.  Increased synthesis of extracellular matrix in mesangial proliferative nephritis.

Authors:  J Floege; R J Johnson; K Gordon; H Iida; P Pritzl; A Yoshimura; C Campbell; C E Alpers; W G Couser
Journal:  Kidney Int       Date:  1991-09       Impact factor: 10.612

6.  Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.

Authors:  R J Johnson; H Iida; C E Alpers; M W Majesky; S M Schwartz; P Pritzi; K Gordon; A M Gown
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

7.  Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat.

Authors:  H Iida; R Seifert; C E Alpers; R G Gronwald; P E Phillips; P Pritzl; K Gordon; A M Gown; R Ross; D F Bowen-Pope
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

8.  Platelet-complement interactions in mesangial proliferative nephritis in the rat.

Authors:  R J Johnson; P Pritzl; H Iida; C E Alpers
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

9.  Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.

Authors:  W A Border; S Okuda; L R Languino; M B Sporn; E Ruoslahti
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

10.  Interleukin-1 beta stimulates human mesangial cells to synthesize and release interleukins-6 and -8.

Authors:  F Abbott; J J Ryan; M Ceska; K Matsushima; C E Sarraf; A J Rees
Journal:  Kidney Int       Date:  1991-10       Impact factor: 10.612

View more
  63 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

3.  Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1).

Authors:  K Hiromura; J W Pippin; M L Fero; J M Roberts; S J Shankland
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 4.  Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis.

Authors:  Eugene Kissin; Joseph H Korn
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

5.  Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus.

Authors:  C Hugo; S J Shankland; D F Bowen-Pope; W G Couser; R J Johnson
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

6.  Macrophage apoptosis in rat crescentic glomerulonephritis.

Authors:  H Y Lan; H Mitsuhashi; Y Y Ng; D J Nikolic-Paterson; N Yang; W Mu; R C Atkins
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

7.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

Authors:  Jeremy S Duffield; Stuart J Forbes; Christothea M Constandinou; Spike Clay; Marina Partolina; Srilatha Vuthoori; Shengji Wu; Richard Lang; John P Iredale
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

8.  Apoptosis and proliferation in childhood acute proliferative glomerulonephritis.

Authors:  Fatih Ozaltin; Nesrin Besbas; Aysin Bakkaloglu; Safak Gucer; Rezan Topaloglu; Seza Ozen; Gulsev Kale; Melda Caglar
Journal:  Pediatr Nephrol       Date:  2005-06-18       Impact factor: 3.714

9.  Development of factors to convert frequency to rate for beta-cell replication and apoptosis quantified by time-lapse video microscopy and immunohistochemistry.

Authors:  Yoshifumi Saisho; Erica Manesso; Tatyana Gurlo; Chang-Jiang Huang; Gianna M Toffolo; Claudio Cobelli; Peter C Butler
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-21       Impact factor: 4.310

10.  SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.

Authors:  R H Pichler; J A Bassuk; C Hugo; M J Reed; E Eng; K L Gordon; J Pippin; C E Alpers; W G Couser; E H Sage; R J Johnson
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.